Literature DB >> 23332932

Cardiomyopathies due to homoplasmic mitochondrial tRNA mutations: morphologic and molecular features.

Carla Giordano1, Elena Perli, Maurizia Orlandi, Annalinda Pisano, Helen A Tuppen, Langping He, Rocco Ierinò, Luciano Petruzziello, Amedeo Terzi, Camillo Autore, Vincenzo Petrozza, Pietro Gallo, Robert W Taylor, Giulia d'Amati.   

Abstract

Isolated hypertrophic cardiomyopathy may represent the sole clinical feature of a mitochondrial disorder in adult patients. The clinical outcome is characterized by a rapid progression to dilation and failure. A mitochondrial etiology in these cases is not obvious at clinical investigation and may represent an unexpected finding at autopsy or after cardiac transplant. We describe the morphologic, biochemical, and molecular features of hearts from 3 transplanted patients with isolated mitochondrial cardiomyopathy caused by homoplasmic mutations in the MTTI gene, coding for mitochondrial isoleucine tRNA (mt-tRNA(Ile)). On gross examination, the 3 hearts showed a symmetric pattern of hypertrophy. At histology, cardiomyocytes were hypertrophic and showed sarcoplasmic vacuoles filled with granules that stain with antimitochondrial antibodies. On frozen sections, the combined cytochrome c oxidase (COX)/succinate dehydrogenase stain showed a large prevalence of COX-deficient cardiomyocytes. Mitochondrially encoded COX subunit I was almost absent on immunohistochemistry, whereas the nuclear-encoded COX subunit IV was normally expressed. Ultrastructural analysis confirmed the marked mitochondrial proliferation. Biochemical studies of cardiac homogenates revealed a combined respiratory chain defect. Quantitative restriction fragment length polymorphism analysis of DNA from cardiac homogenate confirmed that the mt-tRNA mutations were also detected in the patient's blood. High-resolution Northern blot analysis showed a marked decrease in the steady-state level of mt-tRNA(Ile), confirming pathogenicity. In conclusion, pathologists play a major role in unraveling the mitochondrial etiology of isolated hypertrophic cardiomyopathies, provided that a detailed diagnostic flowchart is followed. Once the mitochondrial etiology is clearly defined, molecular analyses on the heart are an invaluable tool to assign mutation pathogenicity.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23332932     DOI: 10.1016/j.humpath.2012.10.011

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  12 in total

1.  Cardiac manifestations of mitochondrial disorders.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Tex Heart Inst J       Date:  2013

Review 2.  Cardiac complications in inherited mitochondrial diseases.

Authors:  Mohaddeseh Behjati; Mohammad Reza Sabri; Masood Etemadi Far; Majid Nejati
Journal:  Heart Fail Rev       Date:  2021-03       Impact factor: 4.214

3.  Gitelman-Like Syndrome Caused by Pathogenic Variants in mtDNA.

Authors:  Daan Viering; Karl P Schlingmann; Marguerite Hureaux; Tom Nijenhuis; Andrew Mallett; Melanie M Y Chan; André van Beek; Albertien M van Eerde; Jean-Marie Coulibaly; Marion Vallet; Stéphane Decramer; Solenne Pelletier; Günter Klaus; Martin Kömhoff; Rolf Beetz; Chirag Patel; Mohan Shenoy; Eric J Steenbergen; Glenn Anderson; Ernie M H F Bongers; Carsten Bergmann; Daan Panneman; Richard J Rodenburg; Robert Kleta; Pascal Houillier; Martin Konrad; Rosa Vargas-Poussou; Nine V A M Knoers; Detlef Bockenhauer; Jeroen H F de Baaij
Journal:  J Am Soc Nephrol       Date:  2021-10-04       Impact factor: 10.121

Review 4.  Study of respiratory chain dysfunction in heart disease.

Authors:  Seyyed Hossein Hassanpour; Mohammad Amin Dehghani; Seyyedeh Zeinab Karami
Journal:  J Cardiovasc Thorac Res       Date:  2018-03-17

5.  Novel compound mutations in the mitochondrial translation elongation factor (TSFM) gene cause severe cardiomyopathy with myocardial fibro-adipose replacement.

Authors:  Elena Perli; Annalinda Pisano; Ruth I C Glasgow; Miriam Carbo; Steven A Hardy; Gavin Falkous; Langping He; Bruna Cerbelli; Maria Gemma Pignataro; Elisabetta Zacara; Federica Re; Paola Lilla Della Monica; Veronica Morea; Penelope E Bonnen; Robert W Taylor; Giulia d'Amati; Carla Giordano
Journal:  Sci Rep       Date:  2019-03-25       Impact factor: 4.379

6.  Combined obstructive hypertrophic cardiomyopathy and double outlet right ventricle in an infant with Down syndrome.

Authors:  Laxmi Ghimire; Ossama Tawffik; Valerie A Schroeder
Journal:  Am J Case Rep       Date:  2013-11-01

7.  tURn the lights on: mitochondrial transport-RNAs and cardiovascular disease.

Authors:  Gabriele Giacomo Schiattarella; Bruno Trimarco; Cinzia Perrino; Giovanni Esposito
Journal:  J Am Heart Assoc       Date:  2014-02-28       Impact factor: 5.501

Review 8.  Transfer RNA and human disease.

Authors:  Jamie A Abbott; Christopher S Francklyn; Susan M Robey-Bond
Journal:  Front Genet       Date:  2014-06-03       Impact factor: 4.599

Review 9.  Mitochondrial disease: genetics and management.

Authors:  Yi Shiau Ng; Doug M Turnbull
Journal:  J Neurol       Date:  2015-08-28       Impact factor: 4.849

Review 10.  The aetiology of cardiovascular disease: a role for mitochondrial DNA?

Authors:  Marianne Venter; Francois H van der Westhuizen; Joanna L Elson
Journal:  Cardiovasc J Afr       Date:  2017-08-25       Impact factor: 1.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.